erdosteine has been researched along with Inflammation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Atik, H; Atik, O; Avci, G; Birdane, FM; Birdane, YO; Turkmen, R | 1 |
| Cao, L; Cui, G; Gao, H; Han, S; Jiang, X; Li, P; Li, S; Ma, Z; Ning, X; Ping, F; Zhang, F | 1 |
| Anzueto, A; Cazzola, M; Celli, BR; Matera, MG; Page, CP; Wedzicha, JA | 1 |
| Chu, X; Huang, X; Ma, X; Ni, B; Tan, G; Xi, Y; You, H; Zhang, R | 1 |
| Fraňová, S; Jošková, M; Kazimierová, I; Molitorisová, M; Pappová, L; Šutovská, M | 1 |
| Dal Negro, RW; Turco, P; Visconti, M | 1 |
| Hayashi, K; Hosoe, H; Kaise, T; Ohmori, K | 1 |
1 review(s) available for erdosteine and Inflammation
| Article | Year |
|---|---|
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Antioxidants; Expectorants; Humans; Inflammation; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Sulfhydryl Compounds | 2023 |
1 trial(s) available for erdosteine and Inflammation
| Article | Year |
|---|---|
Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Topics: Administration, Oral; Adult; Aged; Albuterol; Antioxidants; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Expectorants; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Thioglycolates; Thiophenes | 2015 |
5 other study(ies) available for erdosteine and Inflammation
| Article | Year |
|---|---|
The protective effects of erdosteine on subacute diazinon-induced oxidative stress and inflammation in rats.
Topics: Acetylcholinesterase; Animals; Diazinon; Inflammation; Insecticides; Male; Organophosphorus Compounds; Oxidative Stress; Rats; Rats, Wistar; Thioglycolates; Thiophenes | 2022 |
Tissue-Protective Effect of Erdosteine on Multiple-Organ Injuries Induced by Fine Particulate Matter.
Topics: Animals; Antioxidants; Biomarkers; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Expectorants; Inflammation; Kidney; Lung Injury; Male; Oxidative Stress; Particulate Matter; Rats; Rats, Wistar; Spleen; Thioglycolates; Thiophenes | 2021 |
Protective effects of Erdosteine on interleukin-1β-stimulated inflammation via inhibiting the activation of MAPK, NF-κB, and Wnt/β-catenin signaling pathways in rat osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Cells, Cultured; Chondrocytes; Dose-Response Relationship, Drug; Extracellular Matrix; Inflammation; Injections, Intra-Articular; Interleukin-1beta; Mitogen-Activated Protein Kinases; NF-kappa B; Osteoarthritis; Rats; Rats, Sprague-Dawley; Signal Transduction; Thioglycolates; Thiophenes; Wnt Signaling Pathway | 2020 |
The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
Topics: Animals; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Cough; Cytokines; Disease Models, Animal; Expectorants; Guinea Pigs; Inflammation; Male; Mucociliary Clearance; Thioglycolates; Thiophenes | 2019 |
Protective effect of erdosteine against hypochlorous acid-induced acute lung injury and lipopolysaccharide-induced neutrophilic lung inflammation in mice.
Topics: Administration, Oral; Animals; Bronchitis; Bronchoalveolar Lavage Fluid; Chronic Disease; Disease Models, Animal; Expectorants; Hypochlorous Acid; Inflammation; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Reactive Oxygen Species; Thioglycolates; Thiophenes; Tumor Necrosis Factor-alpha | 2000 |